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The goal of this review is to integrate - in its two parts - the considerable amount of information that has
accumulated during these recent years over the morphology, biology and functions of astrocytes - first part - and
to illustrate the active role of these cells in pathophysiological processes implicated in various psychiatric and
neurologic disorders – second part.
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Increasing research interest aroused by astrocytes over
the past few years led to a dramatic evolution of the
concept regarding their structure and function. Ubi-
quitously present in all regions of the central nervous
system (CNS), astrocytes are specialized glial cells, pro-
viding structural and functional support for neurons.
Although considered for more than 100 years as a
homogenous cell population, it is known today that glia
encompasses various morphological entities that coexist;
each of these populations are characterized by a parti-
cular molecular signature and specific functions related
to their microenvironment. Moreover, dysfunctions of
astrocytes might contribute to CNS pathological remo-
delling and disease [1].Review
Short history
The concept of neuroglia, introduced by Rudolf Virchow
in 1858, described a connective substance of the brain,
represented most likely by “fibers and intercellular
masses”. Otto Deiters, a German scientist, was the first
who, in the second half of the 19th century, drew the as-
trocytes as stellate cells; later, Jacob Henle and Friedrich
Merkel observed the network formed by the astrocytes
processes within the grey matter [2]. Yet it was Camillo* Correspondence: a_sovrea@yahoo.com
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distribution, and reproduction in any mediumGolgi (1872) the first who detailed and described the
morphology of glial cells by using the silver-chromate
technique (a black staining reaction); he observed that
some glial cells (known today as protoplasmic astrocytes)
displayed endfeet on their processes, attached to the blood
vessels. His theory postulated that there was a link
between the morphology and function of astrocytes in
the CNS; regarded as the “glue” of the brain, glial cells
established an interconnection between vessels and pa-
renchyma, therefore being responsible for metabolic ex-
changes. In 1893 Michael von Lenhossek contrived the
term “astrocyte” that illustrated the morphology of these
cells. The origin of this term arouse from a combination
of the latin word for stars, astra, with the word for cell,
cyte, thus a star-shaped cell [3]. Astrocytes were further
classified into protoplasmic (found in the grey matter) and
fibrous (within the white matter) [2-4].
At the beginning of the 20th century the morpho-
logical heterogeneity of the CNS glia was definitely set.
However, only when Santiago Ramόn y Cajal (1913) has
developed the gold chloride-sublimate staining tech-
nique, the first specific stain for astrocytes, this diversity
was acknowledged. Cajal is considered the promoter of
the future stem properties of neuroglia since, using this
method, he proved that astrocytes originate from radial
glia and undergo cell division in the adult brain. Nume-
rous functions of astrocytes (e.g. neuronal nutrition and
metabolism, nervous tissue homeostasis, brain cytoarchi-
tecture, glial scar formation) were further determined,ntral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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cytes essential brain “homeostatic cells” either in normal
or pathologic conditions [5].
Yet, the gains regarding the functions of astrocytes
were shadowed by the lack of adequate techniques that
could have promoted them, versus neurons of which
value was overstated by the neuronal doctrine [2].
Phylogenetic evolution
From the phylogenetical point of view, the organization
of a centralized nervous system was marked by the ap-
pearance of astrocytes [5].
An interesting aspect is the constant augmentation the
astrocytes/neurons ratio that parallelized the evolution of
the brain (about 0.16 in nematodes to 0.33 in rodents, and
reaching up to 1.65 astrocytes per neuron in the human
cortex) [6]. It is considered that, in the human brain, to
each neuron correspond 10 glial cells. In smaller creatures’
brain, the number of glial cells corresponding to a neuron
is significantly reduced [7].
The primordial astrocytes performed a wide range of
functions in the development of the nervous system. In
nematodes, the astrocytes are not only involved in neu-
ronal development, but also enable the sensory functions
[5]. Moreover, the astrocytes’ performances improve with
the evolutionary stages. For example, in arthropods glial
cells fulfill an additional role, organizing the neurons in
functional definite nervous centers [5]. In crustaceans, in-
sects and cephalopods, even in some vertebrates (sharks),
the astrocytes form the blood-brain barrier (BBB) or the
hemolymph-brain barrier (HBB) isolating the nervous tis-
sue from the rest of the body [5]. Primordial astrocytes
also envelop the axons therefore being the predecessors of
the myelin forming cells; the astroglial sheath of the axons
improves the propagation of the action potential [5]. In
higher vertebrates, astrocytes’ role in maintaining the BBB
function is completed by the endothelial cells. Besides,
in this stage of evolution, astrocytes specialize for the
defensive function [5]. In humans, astrocytes achieve their
greatest morphologic and functional complexity. For
example, neocortex humans astrocytes compared to those
of rodents, are 2.5 times larger, their processes are 10
times more numerous and they display particular histo-
logical features; the action potential velocity is also 4 times
higher [7].
Stem cells and astrocytes differentiation
Initially astrocytes were identified due to their star-shaped
morphology and presence of the glial fibrils. Nowadays
these features are almost outdated.
The diversity of astrocytes is justified by two main fac-
tors: the heterogeneity of glial precursors and the various
pathways of specific differentiation, both being influenced
by the extracellular environment. Recent in vitro studiesreported that growth factors levels activate in astrocytes
the gene expression and regulate the transcription factors
so that the subsets of progenitors are spontaneously
engaged in different pathways of development [8]. During
their differentiation, between the glial precursors and the
microenvironment there is a mutual influence: cells
secrete various soluble factors, and, on the other hand, the
extracellular matrix (ECM) molecules (e.g. lectican and
tenascins family) have the ability to stimulate or to inhibit
cells proliferation, maturation and migration [9,10]. Thus,
in his study, Haas C. et al. in 2012, observed that by treat-
ing GRP in vitro with specific culture media, different
astrocytic phenotypes were obtained (e.g. A2B5-/GFAP+
with a flat morphology fibroblast-like when treated with
fetal bovine serum and A2B5+/GFAP+ star-shaped astro-
cytes when treated with both basic fibroblast growth fac-
tor (bFGF) and ciliary neurotrophic factor (CNTF) [8].
For example, if we consider a multipotent stem cell as a
source of astrocytes, but initially, this cell has produced
neuronal precursors, the turn towards glial differentiation
implies a multi-step process. At first, a specific receptor
on the surface of the multipotent stem cell modifies its
structure to gain affinity for growth factors such as: fibro-
blast growth factor (FGF) and epidermal growth factor
(EGF); then, the resulting glial precursor is subjected to
the action of signalling molecules (e.g. CNTF, bone mor-
phogenetic proteins (BMF) and EGF) that will control and
continue its maturation [9,10].
However, further research is needed in order to identify
the heterogeneous subpopulations of astrocytes progeni-
tors and accurately characterise them by new antigenic
markers, physiological properties or molecular profiles [1].
At present, three distinct pools of glial progenitors
have been described in the germinal niches of the cere-
bral cortex: a) radial cells of the ventricular zone b) post-
natal glial progenitor cells of the subventricular zone
and c) glial-restricted precursors (GRP) - also found in
the embryonic spinal cord (see Table 1) [3,8].
The grey matter protoplasmic astrocytes are mostly
generated by embryonic radial glia but also from the
intermediate progenitors arisen from neonatal subventri-
cular zones. Due to their different origin, the two popu-
lations of astrocytes will display different patterns of
gene expression, which will enable potential different
functions. The white matter fibrous astrocytes originate,
instead, mainly from neonatal subventricular zone pro-
genitors [1].
Astrocytes-like neural progenitors
An unexpected finding in the astrocyte research is the
identification in the adult neurogenic zones - subventri-
cular zone (SVZ) and subgranular zone (SGZ) - of a sub-
type of astrocytes considered to be the local stem cells.
Regarded as mature astrocytes due to the expression of
Table 1 Ontogenetic astrocyte progenitor pools
Radial glia Postnatal glial progenitor cells Glial restricted precursors
Origin Neuroepithelial cells [1] • Radial glia [11,12] Neuroepithelial cells skipping the radial glia stage [13,14]
• Dlx2 (distal-less homeobox 2) [3]
• Local glial progenitors [1]
Location Ventricular zone [1] • Subventricular zone • Embryonic spinal
cord [8]
• Optic nerve [8]
• Dorso-lateral subventricular zone
• Marginal zone [1,11,12]
Characteristics Multipotential cells [11,12] • Multipotential cells Tripotential cells [8] • Bipotential cells O-2A, O-2A/OPC [8,15]
• Bipotential cells [3]
Roles • Progenitors for neurons
and glial cells
• Intermediate progenitors for
astrocytes and oligodendrocytes [3]
• Promote
neuroprotection
• Tumor genesis (oligoastrocytomas,
multiform glioblastomas) [15]
• Guidance of neuronal
migration [11,12]






• Star shaped specialised
cortical astrocytes
• Cortical astrocytes • Self-renewal • Astrocytes type 2 and oligodendrocytes
(in vitro)
• White matter astrocytes • Astrocytes types 1,
2 and
• Bergmann glia in the
cerebellum [3,16]
• Oligodendrocytes [3] • Oligodendrocytes
[8]
• Oligodendrocytes (in vivo) [8,15]
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play features of both radial glia and neural progenitors
(e.g. synaptic mediators’ release) [1].
It was demonstrated that the specific pro-neural genes
(e.g. neurogenin-2 and Mash1) enable these astrocytes to
regain their stem cells properties being able to differen-
tiate into neurons [1]. Additionally, the embryonic extra-
cellular matrix molecules present in the neurogenic niche
are capable to maintain these cells’ “stemness” [1,17].
In the adult SVZ and SGZ, two distinct population of
neural progenitors (multipotent neural stem cells) express
GFAP [1,18-20]. The SVZ progenitors and give rise to
neuroblasts which migrate to the olfactory bulb (to be-
come olfactory interneurons) [1,19-22]. GFAP-expressing
cells found in the SVZ are also been referred to as
astrocytes-like cells or B cells. From the histological point
of view, these cells are irregular in shape, filling in the
spaces between neighbouring cells; their cytoplasm is pale
with few organelles (e.g. free ribosomes) but numerous
intermediate filaments; the nuclei are also irregular due
to the invaginations on their surface. There are signifi-
cant differences between the two types of SVZ astro-
cytes. Type 1 (i.e. B1 cells) are larger, with euchromatic
nuclei and are located in the proximity of the epen-
dymal cells. Type 2 (i.e. B2 cells) are smaller, with hyper-
chromatic nuclei and are mostly adjacent to the striatalparenchyma. The SGZ neural progenitors generate new-
born granular neurons [1].
Another type of stem cell which expresses GFAP can
be found in the adult SVZ but it is not certain that these
adult stem cells are, in fact, astrocytes. They have diffe-
rent molecular features, because they express nestin (an
intermediate filament), that characterise only embryonic
astrocytes, reactive astrocytes or neuroblasts and inter-
mediate progenitors [1].
Considering the high plasticity of astrocytes, the GFAP
expressing cells in the neurogenic niche can simul-
taneously behave as both astrocytic and neural stem
cells [1].
Astrocytic markers and stains
Important advances in technologies to study the nervous
tissue enabled the knowledge of astrocytes characteristics
(see Table 2), Figures 1, 2 and 3. (All images presented in
here, are microphotographs of human brain samples pre-
levated by autopsy in compliance with the Protocol ela-
borated by the Ethics Committee of “Iuliu Hatieganu”
University of Medicine and Pharmacy Cluj-Napoca).
For example, the grey matter protoplasmic astrocytes,
are generated from embryonic radial glia and, to a lesser
extent, from intermediate progenitors migrating from
the neonatal subventricular zones. These two pathways
Table 2 Astrocytic markers and stains
Procedures Characteristics Results Observation
Hematoxylin and eosin stain
(H-E) [23]
Routine staining for basic
morphology
Nuclear details • Astrocytes are difficult to identify (nuclei:
small, pale, ovoidal, euchromatic and
centrally situated, are mimicking those of
small neurons; cytoplasm and cellular




• The occasionally pericellular hallo (autolitic
modification) impose a differential
diagnosis with the oligodendrocytes [23]
Mallory’s (phosphotungstic
acid – hematoxylin) stain [24]
Special stain Astrocyte processes
(deep blue)
Orange-acridine stain [24] Special stain Cellular body • Reveals the astrocytic hyperplasia, without
the modification of the cytoplasm aspects
[24]
Metallic impregnations [23] Nuclei • Reveals the cellular characteristic star-
shaped aspect
• Del Rio Hortega method • Special technique with
ammonia silver carbonate
Cytoplasm processes • The abundant cytoplasm surrounding the
nuclei differentiates the astrocytes from
oligodendrocyte
• Ramon y Cajal method
(see Figures 1 and 2)
• Special technique with
gold chloride
• The fibrillar aspect of the cytoplasm is due
to the material formed by the aggregation
of GFAP intermediate filaments
• Golgi stain • Special technique with
silver nitrate
• The vascular endfeet are easy to identify.
• Protoplasmic astrocytes, due to their
proximity to the blood vessels, are able to
contact the vessel directly by their cell
body
• The perivascular hallo is considered to be
an artefact [23].
Electron microscopy [24] Cytoplasm intermediate
GFAP
• Cytoplasm pale , with lack of organelles
• The clear, perivascular spaces indicate
excessive dilatation of astrocytic processes
due to water imbibitions
• The ultrastructural resemblance between
normal and well differentiated neoplastic
astrocytes is one of the arguments against
the use of this method for positive
diagnosis of low grade glioma [24]
Immunohistochemistry GFAP represents an integrator of the cellular
space, but it is also implicated in complex
cellular events, such as cytoskeleton
reorganisation, myelination, cellular
adhesion and several signalling pathways
[23,24].
• GFAP (intracytoplasmic
protein, with 50 Kda
molecular weight,
considered the major
component of glial fibrils
and a marker of astrocytic
differentiation) [23,24]
(see Figure 3)
• Golden standard for the
definition of astrocytes
Cell body • Fibrillary astrocytes contain a massive
amount of GFAP in their cell bodies and
processes unlike protoplasmic astrocyte.







• Protoplasmic astrocytes are much larger
than their GFAP-defined profiles due to the
presence of numerous fine processes that
are GFAP-negative
• Laboratories (e.g. GF2 DAKO
clone; Astro 1) [23,24]
• In astrocytomas, along with the
enhancement of malignity, the intracellular
quantity of GFAP is progressively reduced;
therefore the evaluation of GFAP
immunohistochemical staining will enable
the immunophenotypic characterisation of
the investigated glial tumors and the
confirmation of histopathological diagnosis
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Table 2 Astrocytic markers and stains (Continued)
• Not all the cells in the CNS that express
GFAP are astrocytes (e.g: astrocyte-like cells
from the SVZ-derived from radial glia,
ependymal cells) [1,25,26]
• GFAP has also been located in rat kidney
glomeruli and peritubular fibroblasts [1,27],
Leydig cells of the testis [1,28], skin
keratinocytes [1,29], osteocytes of bones,
chondrocytes of epiglottis, bronchus [1,30],
and stellate-shaped cells of the pancreas
and liver [1]
S100B (belongs to the S100
family of EF-band calcium
binding proteins [1,31]).
There are different clones of
anti S100 antibodies,
characteristic to the different
research laboratories
(e.g. MAB079, CBL410.)
Cell membrane • Expressed by a subtype of mature
astrocytes that ensheath blood vessels and
by NG2-expressing astrocytes [1,31]
Other astrocytic markers
• GLT-1 (the glutamate
transporters GLAST) [6]
• GLT-1 is expressed by all astrocytes and
provide punctuate staining [6]
• Human EAAT2 (excitatory
amino acids, 1 and 2 for
human brain) [6]
• Glycogen granules [6] Cytoplasm
• Gglutamine synthase (GS)
[1,32-35]
GS- enzyme that catalyzes
the conversion of ammonia
and glutamate to glutamine
Cytoplasm GS is expressed also by oligodendrocytes
[1,32-35]
Kir4.1 (inwardly rectifying K+
channels) [1,36,37]
Kir4.1 are only expressed by a subset of
astrocytes [37]
• Aquaporin 4 channels [1,38] Cell processes • Aquaporin 4 channels is localized in some
parts of the astrocytic processes rendering





Genome • All astrocytes
Battery of tests [40]• GFAP-





Combinatorial approach • Nine different classes of astrocytes has
been identified, that included Bergmann
glia, ependymal glia, fibrous astrocytes,
marginal glia, perivascular glia,
protoplasmic astrocytes, radial glia,
tanycytes and velate glia [3,40]
• GFAP expression glutamate
response [41]
• Define the phenotype of an astrocyte
population as (GFAP+/NG2−; T+/R−) which
is distinct from NG2-glia (GFAP−/NG2+ T−/
R+) [41]
Dye-filling techniques [6,42]
(e.g. sharp electrode, patch
clamp recordings, single cell
electroporation)
Special techniques that
identify cells recorded in situ
after filling them with a dye
present in a micro-electrode
Cell body • This technique has the advantage that the
cells to be studied can be preselected in
living tissue [6,42]
It is suplemented by use of
presumed astrocyte-
Cell processes • However, proteins and promoter activation
are subjects to change. Hence one can
have a GFAP(−) cell that one should call an
astrocyte because it has these other
properties [6,42]
Specific promoters to drive
synthesis of fluorescent
proteins
• Using these procedures the domain
organisation of astrocytes has been
demonstrated along with the fusiform
morphology of astrocyte nucleus, both
playing a possible role in pathology
[3,43,44]
Cell body • Mice specific for astrocytes express [1]
Şovrea and Boşca Journal of Molecular Psychiatry 2013, 1:18 Page 5 of 13
http://www.jmolecularpsychiatry.com/content/1/18
Table 2 Astrocytic markers and stains (Continued)
Transgenic techniques
(use transgenic mice) [1]
Visualize fluorescent
astrocytes
Cell processes - GFP
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patterns of gene expression and possibly different
functions.
On the other hand, the white matter fibrous astrocytes
are predominantly generated from neonatal subventricu-
lar zone progenitors [1].
Yet, it is important to recognize that subsets of proge-
nitors will spontaneously differentiate in culture, as the
intrinsic program of the cells modulates the process of cell
division and differentiation together with culture con-
ditions. Nevertheless, treatment of GRP cultures with
fetal bovine serum (FBS) resulted in the production of
A2B5−/GFAP + astrocytes with a fibroblastlike flat morph-
ology, whereas exposure to basic fibroblast growth factor
(bFGF) together with ciliary neurotrophic factor (CNTF)
produced mostly process-bearing A2B5+/GFAP + astro-
cytes. Further research is needed to elucidate the identity
of the different classes of intermediate progenitors or to
obtain a clear antigenic signature of the lineage [8].
The development of astrocytes from a multipotent
stem cell that prior to this has produced neuronal pre-
cursor cells, implies a specific differentiation via a multi-
step process. The switch toward the glial differentiation isFigure 1 Astrocytes overview. Metalic impregnation Ramon Y Cajal
Ob. 20x. Human brain (personal collection).regulated by a change in receptor composition on the cell
surface and responsiveness to fibroblast growth factor
(FGF) and epidermal growth factor (EGF); futhermore,
signaling molecules like CNTF, bone morphogenetic pro-
teins (BMF), and EGF will continue to drive the glial pre-
cursor cell into the astroglial direction. However, the early
astrocytes will interact with their microenvironment not
only by releasing and responding to diverse soluble fac-
tors, but also expressing a wide range of extracellular
matrix (ECM) molecules, as proteoglycans (lectican family)
and tenascins. Lately it is considered that these ECM
molecules have the ability to participate in glial develop-
ment (e.g. the matrix protein Tenascin C (Tnc), proved to
be an important regulator of astrocyte precursor cell pro-
liferation, maturation and migration during spinal cord
development) and those expressed by reactive astrocytes
under pathophysiological conditions, are known to act
mostly in an inhibitory fashion [9,10].
Astrocytes as a source of stem cells
The most recent and exciting finding in the astrocyte field,
which challenges the traditional definition of astrocyte it-
self, is the discovery that there is a subclass of matureFigure 2 Astrocytes overview. Metalic impregnation Ramon Y Cajal
Ob. 40x. Human brain (personal collection).
Figure 3 Astrocytes overview. GFAP Clone GF2 DAKO. Human
brain. Ob. 20x. (personal collection).
Figure 4 Protoplasmic astrocyte proximal to a blood vessel.
Metallic impregnation Ramon Y Cajal. Ob. 20x. Human brain
(personal collection).
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neurogenic zones. The GFAP-expressing stem cells have
characteristics of embryonic radial glia and mature astro-
cytes, but display subtle differences and retain properties
of neural progenitors. These stem cells act in concert with
resident astrocytes to contribute to cell genesis and main-
taining the neurogenic environment, the niche. Perhaps
these cells are retained in a transitional stage between
radial glia and astrocytes, due to the persistence of embry-
onic extracellular matrix molecules. This permissive envi-
ronment in the neurogenic niche allows the retention of
intrinsic genetic programs to maintain “stemness” [1,17].
It was shown that, the proneural genes neurogenin-2 and
Mash1 possess the ability to reprogram these astrocytes to
stem cells that can generate neurons [1].
In the adult subventricular zone (SVZ) and subgra-
nular zone (SGZ), two distinct population of neural pro-
genitors (multipotent neural stem cells) express GFAP
[1,18-20] and give rise to neuroblasts that either migrate
to the olfactory bulb (to become olfactory interneurons)
[1,19,21,22] or generate newborn granule neurons. GFAP-
expressing cells of the SVZ have been termed SVZ astro-
cytes, astrocyte-like cells or B cells. The histology of these
cells comprises irregular contours that filled the spaces
between neighbouring cells, irregular nuclei with inva-
ginations, and light cytoplasm with few free ribosomes.
They also expressed abundant intermediate filaments.
Differences were found between the two types of
astrocyte-like cells. Type B1 cells are larger than type
B2 cells and possess euchromatic nuclei; they are adja-
cent to ependymal cells. Type B2 cells are smaller withhyperchromatic nuclei and are mostly located at the
interface with the striatal parenchyma [1].
Another type of stem cell which expresses GFAP can
be found in the adult SVZ but it is questionable whether
these adult stem cells really belong to the astrocyte fa-
mily. They has different molecular features, because
they express nestin (an intermediate filament), that
characterise only embryonic astrocytes, reactive astro-
cytes or neuroblastes and intermediate progenitors [1].
In conclusion, there is much need for further studies
to be conducted in an attempt of finding new antigenic
markers, physiological properties or molecular profiles
for a better definition of these varieties of stem cells and
to answer to challenging question as the ability of every
astrocyte to revert to stem cells given the right environ-
ment [1].
Astrocytic markers and stains
Many novel tools to study astrocytes were given by the
technological advances over the past decades. From the
early Golgi stains to immunostaining for glial fibrils, or
the recent dye-filling techniques (e.g. sharp electrode,
patch clamp recordings, single cell electroporation), and
transgenic approaches to visualize fluorescent astrocytes,
our understanding of astrocyte characteristics has dra-
matically evolved [1] (see Table 2), Figures 1, 2 and 3.
The morphological features and the close relationships
with both neurons and capillaries are the most constant
characteristics that can be used to define the astrocytic
phenotype [3] (see Figure 4).
Table 3 Types of astrocytes
Types of astrocytes Location Morphology Functions Particularities
Protoplasmic astrocytes Uniformly
distributed within
the grey matter [3]
Bushy appearance, with
numerous short, branched,
thick processes [50]. The
cell body is ovoid or
fusiform (see Figure 5)
• Form the blood–brain barrier Their processes exhibit endfeet
enveloping the synapses and the
blood vessels [51]. The processes
express
• Regulate the blood flow
• Neuronal metabolism • Receptors for neurotransmitters,
cytokines, growth factors
• Implicated in the synapse
function
• Transporters
• Fluid, ion, pH and transmitter
homeostasis [45]
• Ion channels [7]. In rodents, there
is minimal overlapping between
the processes of the
neighbouring astrocytes
[43,44,52-54]. In humans, the
superposition of the domains
occupied by the astrocytes
processes is augmented [3]






long, thin and straight
processes [45]
(see Figure 6)
Their endfeet processes envelop
the nodes of Ranvier and the
blood vessels [45]
Interlaminar astrocytes In the molecular 1st
layer of the cerebral
cortex, next to the
pial surface
Spherical cell bodies and
processes
Unknown Support the calcium
wave propagation in humans [3]
Are found only in humans and
primates. Their processes are
included in the pial glial
membrane, creating a thick
network of GFAP fibers [46-49]
Varicose projection
astrocytes
In the 5th and the
6th layers of the
cerebral cortex
Exhibit 1 to 5 long
processes (up to 1 mm in
length), characterized by
evenly (10 μm) spaced
varicosities [3,46]
Unknown Were identified only in humans










molecular layer of the
cerebellar cortex, in a fan-
like arrangement, exhibiting
pial vascular endfeet [23]
Implicated in synapse function:
capable to interfere with synaptic
transmission by communicating
with neurons via the extracellular
space, by modulating ion
concentrations or transmitter
levels in the synaptic cleft [23]
Display receptors with distinct
biophysical and pharmacological
features allowing them to sense
the activity of synapses [23]
Fananas cells In the molecular
layer of the
cerebellar cortex




Müller cells In the 6th layer of
the visual retina
Supportive cells: they form the
inner and the outer limiting
membranes
The limiting membranes consist of
junctional complexes between the
cellular processes of the Müller
cells
The outer membrane separates
the external segment of the
photoreceptor cells from the cell
bodies and the outer membrane
separates the retina from the
vitrous body [23]
They have an intense metabolic
activity and contain microfilaments




Irregular in shape with
many cytoplasmic
processes extending in the
proximity of the capillaries
and surrounding the
Herring bodies [24]
Their cytoplasm contains lipid
droplets and pigment granules.
They are immunoreactive for GFAP,
vimentin and S100 protein [24]
Inerstitial epiphysial
cells
In the epiphysis Exhibit cytoplasmic
processes
Contain numerous filaments within
their processes [23]
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Figure 6 Fibrous astrocyte. Metallic impregnation Ramon Y Cajal
Ob. 100 immersion. Human brain (personal collection).
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Two major classes of astrocytes were first described in the
19th century by using the Golgi staining, which revealed
their distinct morphological pattern: the protoplasmic and
fibrous astrocytes. Nowadays the classification of astro-
cytes into fibrous and protoplasmic is considered to be
outdated [45]; their morphological diversity can be illus-
trated by specialised classes of astrocytes represented by:
the cerebellar Bergmann and Fananas glia, the Müller glia
of the retina, the pituicytes of the neurohypophysis and
the interstitial cells of the epiphysis. Additionally, in
humans and primates two novel subtypes of astrocytes
have been described: interlaminar astrocytes and varicose
projection astrocytes [3,4,46-49]. (see Table 3) Figures 5
and 6.
The above presented heterogeneity of astrocytes could
arise from separate lineages, plasticity of mature cells
(motility and reactivity after injuries), or association of
both factors [3,54]. Methods of molecular biology, like
time-lapse studies in slice culture, demonstrated the
participation of astrocytes in synaptic remodelling, since
the astrocytic processes are motile and enwrap active
synapses [3,55,56].
It is well-known that mature astrocytes can exhibit
forms of plasticity: motility and reactivity after injuries.
Time lapse studies of astrocytes in acute slice and slice
culture have shown that astrocyte processes act much
like dendritic spines; they are frequently motile and con-
tact active synapses [3,55,57], the role of this feature im-
plying the synaptic remodelling.Figure 5 Protoplasmic astrocyte. Metallic impregnation Ramon Y
Cajal Ob. 100 immersion. Human brain (personal collection).Reactive astrocytes
Astrocytes become reactive notably after injuries, when
the intermediate filament proteins (e.g. GFAP, vimentin,
nestin) are upregulated, becoming larger and there is an
alteration of the domain organization [58,59].
The reactive morphological variants comprise two main
categories: the individualised and the global reactive astro-
cytes. Individualized reactive astrocytes encompass several
types: pilocytic astrocyte, gemistocytic astrocyte, type I
and II Alzheimer astrocytes. The global reactive astrocytes
are the characteristic feature of reactive astrogliosis
(see Table 4) [60].
Reactive astrogliosis, a hallmark of all forms of CNS
injuries, is the result of a multi-step process involving
gradates changes in astrocytes.
Histopathological examinations of human brain in va-
rious neurological conditions have provided different
degrees of reactive astrogliosis. According to Sofroniew
et al., the following categories of reactive astrogliosis can
be identified: mild to moderate astrogliosis, severe astro-
gliosis and the glial scar [60].
Mild to moderate astrogliosis is a manifestation of
various disorders (systemic viral and bacterial infections,
non-penetrating trauma) and also found in the distant
areas surrounding the focal cerebral lesions [60]. The
changes associated with mild to moderate astrogliosis
are reversible if the triggering mechanism has resolved.
In this type of injuries, subtle alterations occur in the
expression of molecules implicated in the cellular acti-
vity: cell structure, energy metabolism, intracellular sig-
naling, membrane transporters and pumps [60].







• In mild and moderate injuries




These cells contain the Rosenthal fibers (specific but inconstant
eosinophilic, cork-screw shaped elements), representing an
advanced stage of cellular degeneration in astrocytoma
• Astrocytoma • Fusiform nuclei





• In mild and moderate injuries
as individual form of reactive astrocytes
• Large, dilatated,
oval cell body
The organelles are numerous and located in the central zone
of the cell body. The glial filaments are also numerous and
peripherally arranged, beneath the plasmalemma
• In gemistocytic astrocytoma

























Ammonia taken up by astrocytes is converted to osmotically
active glutamine, resulting in astrocytic swelling
• In Wilson disease • Vesicular nuclei
with one or more
nucleoli





Changes in molecules expression




• Hypertrophy of cell body • Structural elements: GFAP, nestin,
vimentin
• Inflammatory cell regulators: cytokines, growth factors,
glutathione
• Astrocytes processes are are
numerous and thicker
• Transcriptional regulators: STAT3,
NFκB, Rheb-m TOR, cAMP, Olig2,
SOX9 [61-65].
• Transporters and pumps: AQP4 and Na+/K+ transporters
[61,66-69]
• Glutamate transporter [70-73]
• The non-overlapping domains
of individual astrocytes are
preserved
• Vascular regulators: PGE, NO [74,75]
• Energy provision: lactate [76]




• Intense hypertrophy of cell
body
• Remodeling: thrombospondin and Complement C1q [77,78]
• Significant extension of processes • Molecules implicated in oxidative stress and providing
protection from oxidative stress: NO, NOS, SOD,
Glutathione [67,68,79]
• Proliferation
• Overlapping of individual
domains
• Substantial reorganization of
tissue architecture [60]
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modulated by reactive astrocytes can be either upregulated
or downregulated, depending on the trigger or the mo-
ment after the insult. As a result of these alterations,
specific histopathological features can be identified in
astrocytes (see Table 5).
Severe diffuse reactive astrogliosis is characterised by
permanent, pronounced and long-lasting changes and it
is found in the areas surrounding severe focal lesions or
infections, as well as in neurodegeneration [60].
Compact scar formation occurs in most severe injuries,
such as overt tissue damage (e.g. penetrating or contusive
trauma), inflammation initiated by invasive infections or
abscesses, neoplasm and chronic neurodegeneration. Re-
active astrogliosis reaches its highest level of activation:
astrocytes undergo intense proliferation, and their long,
branched processes overlap (see Table 5) [60].
Any cell type in the CNS (e.g. neurons, all types of glial
cells, endothelial cells and leucocytes) is potentially able to
release the molecular mediators of astrogliosis [60]. Sig-
naling pathways and molecules implicated in mediating
specific aspects of reactive astrogliosis include: STAT3
(signal transducer and activator of transcription 3), NFκB
(nuclear factor kappa B), cAMP (cyclic adenosine mono-
phosphate), all these inducing upregulation of structural
molecules (e.g. GFAP, vimentin, nestin) [62,63,80]; more-
over, STAT3 induces astrocyte hypertrophy, scar forma-
tion and exerts anti-inflammatory effect [62]; NFκB exerts
pro-inflammatory effect [63,81]; Olig2, Endothelin-1 in-
duce astrocyte proliferation [65,82].
The newly formed cells in the glial scar derive from
different sources: mature astrocytes that re-enter the cell
cycle, NG2 progenitors and ependymal cells progenitors.
Molecular mediators and triggers leading to prolifera-
tion include: cytokines and growth factors (e.g. IL (inter-
leukin) 6, LIF (leukemia inhibitory factor), CNTF, IL1,
IL10, TGFβ (transforming growth factor), TNFα (tumor
necrosis factor), INFγ (interferon), [63,69]), Toll-like
receptor ligants [83], LPS (lipopolysaccharide), mole-
cules of oxidative stress (e.g. NO (nitric oxide) and ROS
(reactive oxygen species) [67]), modulators and neu-
rotransmitters (e.g. noradrenalin and glutamate [84]),
ischemia associated hypoxia and glucose deprivation
[67], neurodegeneration associated amyloid- beta [85] and
ATP (adenosine triphosphate) released by cell injury [86].
Reactive astrocytes interact with other cell types: fibro-
meningeal cells and NG-2 positive glia and are asso-
ciated with a dense collagenous extracellular matrix to
form complex glial scars [60,62,87]. The changes leading
to scar formation persist even after the triggering factor
has been removed [61,62,88,89].
Recent evidence suggest that the glial scars might have
a beneficial role, as they form narrow, dense and com-
pact barriers; these barriers delimit the periphery ofsevere tissue damage, isolate the lesion, thus preventing
inflammatory cells and infectious agents from spreading
into the healthy parenchyma [90].
Conclusions
This part of the review is an insight into the morphology
and biology of astrocytes, with an emphasis on the latest
findings concerning the novel cell subtypes, the develop-
mental lineages and their functions.
From the very first description of astrocytes in the 19th
century, these cells concept has been at a standstill until
recently when it remarkably progressed.
The variety of glial precursors, their ability to display
stem cells features and different adult astrocytes mor-
phology certify that the astrocytic phenotype is influenced
by both the local cytoarchitecture and the functional re-
quirements in specific brain areas.
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